5 Stocks To Keep an Eye On in 2026, According to Experts
Written by
Dawn Allcot
Edited by
Jenna Klaverweiden
Commitment to Our Readers
GOBankingRates' editorial team is committed to bringing you unbiased reviews and information. We use data-driven methodologies to evaluate financial products and services - our reviews and ratings are not influenced by advertisers. You can read more about our editorial guidelines and our products and services review methodology.
20 Years
Helping You Live Richer
Reviewed
by Experts
Trusted by
Millions of Readers
The Dow Jones Industrial Average hit an all-time high to start the new year. But stocks in many sectors still have plenty of room to grow.
Finance experts pointed out that the healthcare, finance and retail sectors are worth watching in 2026, especially if the U.S. Federal Reserve continues to lower interest rates. With that in mind, here are five stocks to keep an eye on in 2026.
Also see six investing moves to make right now to grow your wealth in 2026.
1. Novo Nordisk ADR (NVO)
Investors are looking at pharmaceutical companies that produce today’s most popular diabetes drugs and GLP-1 weight loss injections. Vince Stanzione, founder and CEO at First Information and author of “The Millionaire Dropout,” revealed he recently bought shares of Novo Nordisk ADR, the Danish manufacturer of Wegovy and Ozempic.
“The stock was up over 150% in 2023/24 before crashing back to earth in 2025 on competition and pricing issues,” he explained. “A lot of the hype has been taken out of the price, and it’s now on a very reasonable forward P/E of around 16, and you’re getting a decent dividend yield of 3%.”
With an oral pill version of Wegovy recently approved, shares of Novo Nordisk could fatten your portfolio in 2026, especially if you can snag them for under $60, which was the trading price in 2023. “I see a solid 50% potential upside in 2026,” Stanzione said.
2. Eli Lilly (LLY)
Dean Lyulkin, co-CEO of private investment firm Cardiff, said he likes Novo Nordisk competitor Eli Lilly and Co., the American manufacturer of tirzepatide injections Zepbound and Mounjaro, as well as Cymbalta, which treats common afflictions like depression and anxiety.
“GLP-1s continue to be the biggest story in the healthcare space,” he said. “So Eli Lilly is a good stock to own.”
Chip manufacturer Nvidia just announced plans to invest $1 billion over the next five years, joining Eli Lilly & Co. in a push to hasten the use of artificial intelligence (AI) for drug development, according to Bloomberg. This bodes well for the company.
Per TipRanks, Eli Lilly has a “Strong Buy” rating, with a high price target of $1,500. On Jan. 21, the stock closed at $1,078.52.
3. TJX Companies Inc. (TJX)
TJX Companies Inc., owner of discount retailers T.J. Maxx, Marshalls, HomeGoods, Homesense and Sierra in the U.S., with additional brands in Canada, Europe and Australia, shows more promise than many other competitors in the retail space.
“Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock,” according to StockInvest.us.
Lyulkin shared what he likes best about the company’s business model. “When it comes to serving the middle-class consumer, they have that market nailed and that’s going to continue,” he said.
4. Costco (COST)
Likewise, Lyulkin said, warehouse club Costco is another stock to watch in 2026. “They had a rough time in 2025, but I think they’ll figure some things out in 2026,” he said.
GOBankingRates recently shared four reasons you should invest in Costco stock this year, including its emphasis on affordable groceries and its membership model that brings in revenue even if sales are down.
Costco stock closed at $982.86 on Jan. 21, with an average price target of $1,056 over the next year and a high target of $1,225, according to Stock Analysis.
5. Bank of America (BAC)
Investors agreed that the financial sector is worth a close look in 2026. Lyulkin specifically mentioned J.P. Morgan and Bank of America as solid investments.
“As the Fed lowers interest rates, we’re going to see a lot of leverage boost some of those financial stocks over the coming 12 months,” he said. “They’re going to be making money hand over fist.”
Bank of America’s stock price of under $60 gives it a retail-investor-friendly entry point, and its low price-to-earnings ratio indicates its value right now.
More From GOBankingRates
